FDA Inspection 1238557 — Antonio Passaro, M.D.
The FDA completed an inspection of Antonio Passaro, M.D. on Apr 12, 2024 in Milan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 12, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Milan (Italy)
Additional details
Clinical Investigator (CI)